Bacteremia risk and outpatient management of febrile patients with sickle cell disease

Pediatrics

Volumn 131, Issue 6, 2013, Pages 1035-1041

  Baskin, Marc N ^a,b   Goh, Xin Lyn ^c   Heeney, Matthew M ^a,b   Harper, Marvin B ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Ambulatory care; Bacteremia; Fever; Sickle c ell disease

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; ALLERGIC REACTION; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; BLOOD CULTURE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FEVER; HEMOLYSIS; HOMOZYGOSITY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORBIDITY; MORTALITY; OUTPATIENT CARE; OXYGEN SATURATION; OXYGEN THERAPY; PATIENT SAFETY; PNEUMOCOCCAL INFECTION; PRACTICE GUIDELINE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SALMONELLA; SCHOOL CHILD; SICKLE CELL ANEMIA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; URBAN POPULATION; VACCINATION;

EID: 84878722169     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-2139     Document Type: Article

References (20)

1. West TB, West DW, Ohene-Frempong K. The presentation, frequency, and outcome of bacteremia among children with sickle cell disease and fever. Pediatr Emerg Care. 1994;10(3):141-143 (Pubitemid 24189712)
2. West DC, Andrada E, Azari R, Rangaswami AA, Kuppermann N. Predictors of bacteremia in febrile children with sickle cell disease. J Pediatr Hematol Oncol. 2002;24 (4):279-283 (Pubitemid 34506615)
3. Wilimas JA, Flynn PM, Harris S, et al. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease. N Engl J Med. 1993;329(7):472-476 (Pubitemid 23222333)
4. Rogers ZR, Morrison RA, Vedro DA, Buchanan GR. Outpatient management of febrile illness in infants and young children with sickle cell anemia. J Pediatr. 1990;117 (5):736-739 (Pubitemid 20382605)
5. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med. 1986;314(25):1593-1599 (Pubitemid 16118215)
6. McIntosh S, Rooks Y, Ritchey AK, Pearson HA. Fever in young children with sickle cell disease. J Pediatr. 1980;96(2):199-204 (Pubitemid 10129396)
7. Powars DR. Natural history of sickle cell disease-the first ten years. Semin Hematol. 1975;12(3):267-285
8. Gill FM, Sleeper LA, Weiner SJ, et al; Cooperative Study of Sickle Cell Disease. Clinical events in the first decade in a cohort of infants with sickle cell disease. Blood. 1995;86(2):776-783
9. Buchanan GR, Glader BE. Leukocyte counts in children with sickle cell disease: comparative values in the steady state, vasoocclusive crisis, and bacterial infection. Am J Dis Child. 1978;132(4):396-398 (Pubitemid 9129610)
10. Quinn CT, Rogers ZR, McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood. 2010;115(17):3447-3452
11. National Heart, Lung, and Blood Institute. Division of Blood Diseases and Resources. The Management of Sickle Cell Disease. 4th ed. Bethesda, MD: National Institute of Health; 2002
12. Frush K, Ware RE, Kinney TR. Emergency department visits by children with sickle hemoglobinopathies: factors associated with hospital admission. Pediatr Emerg Care. 1995;11(1):9-12
13. Rogovik AL, Friedman JN, Persaud J, Goldman RD. Bacterial blood cultures in children with sickle cell disease. Am J Emerg Med. 2010;28(4):511-514
14. Benson JM, Therrell BL Jr. History and current status of newborn screening for hemoglobinopathies. Semin Perinatol. 2010; 34(2):134-144
15. Consensus conference. Newborn screening for sickle cell disease and other hemoglobinopathies. JAMA. 1987;258(9):1205-1209
16. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44(11):1428-1433 (Pubitemid 46801584)
17. Adamkiewicz TV, Silk BJ, Howgate J, et al. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life. Pediatrics. 2008;121(3):562-569
18. Sox CM, Cooper WO, Koepsell TD, DiGiuseppe DL, Christakis DA. Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. JAMA. 2003;290(8): 1057-1061 (Pubitemid 37430446)
19. Vichinsky EP. Comprehensive care in sickle cell disease: its impact on morbidity and mortality. Semin Hematol. 1991;28(3):220-226
20. Norris CF, Smith-Whitley K, McGowan KL. Positive blood cultures in sickle cell disease: time to positivity and clinical outcome. J Pediatr Hematol Oncol. 2003;25(5): 390-395 (Pubitemid 36569971)